SmartX “Brain Supplement” Firm Should Rethink Its Product Claims – NAD
This article was originally published in The Tan Sheet
Executive Summary
Cerebral Success submitted studies that did not test SmartX products or similar formulas, but were limited to findings on separate ingredients. NAD also said even when using the disclaimer “designed to,” an advertiser must provide reasonable support a product will “deliver the touted benefits to consumers.”
You may also be interested in...
Hearing Supplement Improvement Claims Don't Echo Separate Ingredient Studies
National Advertising Division says Bel Marra Health's reliance on ingredient studies with dosage or usage that could not translate to the ingredients in the product failed to support its claims. “Without testing that the ingredients in the quantity found in Hearing Rescue have the claimed effect, the results from these studies cannot be used to support qualified claims that the same ingredients in the product reduce the damage caused by repeated noise exposure and improve hearing,” NAD said following a review from a challenge by the Council for Responsible Nutrition.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade
Sanofi consumer health scientific affairs lead moves to CHPA; change in Bayer’s US consumer health marketing helm; Viatris CCO moves from same post at Moderna; Qnovia expands scientific advisory board; and Powerade powers Girls Inc. scholarships, programs.